SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-10-030915
Filing Date
2010-08-02
Accepted
2010-07-30 21:12:33
Documents
7
Period of Report
2010-07-28
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 VAXGEN, INC 8-K 7-28-2010 form8k.htm 8-K 90993
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 50195
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 16990
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 57237
5 EXHIBIT 10.4 ex10_4.htm EX-10.4 57269
6 EXHIBIT 10.5 ex10_5.htm EX-10.5 55595
7 EXHIBIT 99.1 ex99_1.htm EX-99.1 11162
  Complete submission text file 0001140361-10-030915.txt   341267
Mailing Address 343 OYSTER POINT SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT SOUTH SAN FRANCISCO CA 94080 (650) 624-1000
VAXGEN INC (Filer) CIK: 0001036968 (see all company filings)

IRS No.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26483 | Film No.: 10982551
SIC: 2834 Pharmaceutical Preparations